Results 121 to 130 of about 230,574 (171)

Modulation of gut microbiota in Graves' orbitopathy: Prevotella dominance and atorvastatin's impact. [PDF]

Microbiome
Wang D, Chen Y, Yang J, Zhang Y, Deng X, Liu Y, Chen Y, Yang X, Wang X, Liang C, Xie Q, Hao Y, Yuan H.   +12 more
europepmc   +1 more source

Extracellular vesicles in Graves' disease and Graves' orbitopathy: immunoregulatory mechanisms, biomarkers, and therapeutic potentials. [PDF]

Front Immunol
Chen Y, Yang Y, Yang S, Yuan W, Jiang L, Wei R.   +5 more
europepmc   +1 more source

Therapeutic targets for fibro-inflammation in Graves' orbitopathy. [PDF]

Taiwan J Ophthalmol
Kang YJ, Yoon JS.
europepmc   +1 more source

Pediatric Graves' orbitopathy: TRAb and FT-3 are also prognostic factors in children-A tertiary center study. [PDF]

Thyroid Res
Al-Ghazzawi K, Oeverhaus M, Rama A, Kiewert C, Bechrakis N, Chen Y, Neumann I, Eckstein A.   +7 more
europepmc   +1 more source

Spontaneous Orbital Wall Fracture Secondary to Neglected Graves' Orbitopathy: A Case Report and Review of Current Literature. [PDF]

Case Rep Ophthalmol
Nabie R, Heydarzadeh G, Tahmasbi F.
europepmc   +1 more source

Graves' orbitopathy following Alemtuzumab treatment for multiple sclerosis: a systematic review and real-world insights. [PDF]

Thyroid Res
Patera B, Zaffaroni A, Louka S, Gallo D, Piantanida E, Tanda ML.   +5 more
europepmc   +1 more source

Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy. [PDF]

Eur Thyroid J
Bartalena L, Gallo D, Kahaly GJ, Marinò M, Tanda ML.   +4 more
europepmc   +1 more source

Higher serum IgG4 levels correlate with better quality of life in mild Graves' orbitopathy: a preliminary report. [PDF]

Endocr Connect
Lin CH, Lee YC, Hsiue YC, Wei YH, Lee CW, Yang CY, Fan KC, Yen IW, Lu C, Huang TY, Lin CH, Shih SR.   +11 more
europepmc   +1 more source